These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6975354)

  • 21. Recombinant rabies virus expressing interleukin-6 enhances the immune response in mouse brain.
    Luo J; Zhang B; Wu Y; Tian Q; Mo M; Long T; Mei M; Fan R; Lyu Z; Jiang H; Wu F; Lin Y; Guo X
    Arch Virol; 2018 Jul; 163(7):1889-1895. PubMed ID: 29594364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of rabies in immunodeficient mice.
    Kaplan MM; Wiktor TJ; Koprowski H
    J Immunol; 1975 Jun; 114(6):1761-5. PubMed ID: 1092760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon production and immune response induction in apathogenic rabies virus-infected mice.
    Marcovistz R; Leal EC; Matos DC; Tsiang H
    Acta Virol; 1994 Aug; 38(4):193-7. PubMed ID: 7533478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.
    Hooper DC; Phares TW; Fabis MJ; Roy A
    PLoS Negl Trop Dis; 2009 Oct; 3(10):e535. PubMed ID: 19806203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of T lymphocytes in Rickettsia conorii infection.
    Kokorin IN; Kabanova EA; Shirokova EM; Abrosimova GE; Rybkina NN; Pushkareva Vi
    Acta Virol; 1982 Jan; 26(1-2):91-7. PubMed ID: 6124115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses to nucleic acid vaccines to rabies virus.
    Xiang ZQ; Spitalnik SL; Cheng J; Erikson J; Wojczyk B; Ertl HC
    Virology; 1995 Jun; 209(2):569-79. PubMed ID: 7778289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency analysis of cytolytic T cell precursors (CTL-P) generated in vivo during lethal rabies infection of mice. I. Distinction of CTL-P with different interleukin 2 sensitivity.
    Reddehase MJ; Cox JH; Koszinowski UH
    Eur J Immunol; 1982 Jun; 12(6):519-23. PubMed ID: 6180904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of certain mechanisms of antigen-specific suppression of the immune response].
    Pisarev VM; Stukalov SV
    Biull Eksp Biol Med; 1981 Aug; 92(8):61-3. PubMed ID: 6170364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
    Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression in rabies virus infection mediated by lymphocyte apoptosis.
    Kasempimolporn S; Tirawatnapong T; Saengseesom W; Nookhai S; Sitprija V
    Jpn J Infect Dis; 2001 Aug; 54(4):144-7. PubMed ID: 11684783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection.
    Doherty PC; Allan JE
    Eur J Immunol; 1986 Oct; 16(10):1237-42. PubMed ID: 3490385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction.
    Basten A; Miller JF; Loblay R; Johnson P; Gamble J; Chia E; Pritchard-Briscoe H; Callard R; McKenzie IF
    Eur J Immunol; 1978 May; 8(5):360-70. PubMed ID: 308454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of cell-mediated immunity by street rabies virus.
    Wiktor TJ; Doherty PC; Koprowski H
    J Exp Med; 1977 Jun; 145(6):1617-22. PubMed ID: 301176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to Plasmodium yoelii: kinetics of the generation of T and B lymphocytes that passively transfer protective immunity against virulent challenge.
    Fahey JR; Spitalny GL
    Cell Immunol; 1986 Apr; 98(2):486-95. PubMed ID: 3489552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.